Discover what clinical trials are, why they're vital for new treatments, and how you can participate in life-changing medical ...

Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...

The Launch-HTN trial is the largest trial of an aldosterone synthase inhibitor completed in participants with uncontrolled or treatment resistant hypertension – – Lorundrostat 50 mg once daily ...

References: Merck announces phase 3 HYPERION study of Winrevair™ (sotatercept-csrk) met primary endpoint in recently diagnosed adults with pulmonary arterial hypertension (PAH).

How ECAs Help Solve Clinical Trial Challenges. ECAs can address these issues by using existing patient data. Instead of requiring newly recruited patients to participate in placebo arms, life ...

Baystreet.ca News Commentary – As cancer rates continue to climb worldwide, the race to develop better, faster, and more ...

Baystreet.ca News Commentary – The rising burden of cancer is poised to strain both healthcare systems and patient finances, ...

Research shows unpredictable caregiving alters brain responses to threats, highlighting the need for stable environments in childhood for healthy development.

AnaptysBio announces positive results from phase 2b trial of rosnilimab to treat rheumatoid arthritis: San Diego Thursday, June 5, 2025, 18:00 Hrs [IST] AnaptysBio, Inc., a clinic ...

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

The open benchmark competition will evaluate the ability of AI-powered virtual cell models to generalize to new cell contexts ...